Biotech Values

[Preciouslife1]

Great morn Dew...Epigenetics companies....

Epigentek Group Inc. is the leading developer and provider of innovative technologies for epigenetic-related products. The company has developed a comprehensive portfolio of more than 400 proprietary products to provide complete and systematic solutions for epigenetics-related research and drug discovery.

Gmr Epigenetics Corporation Company
This company profile is for the private company Gmr Epigenetics Corporation, located in Palo Alto, CA.
Gmr Epigenetics Corporation's line of business is mfg pharmaceutical preparations.

Sigma-Aldrich today announced the launch of its Imprint(TM) Chromatin Immunoprecipitation Kit for epigenetic research (http://www.sigma.com/chip). The Imprint(TM) ChIP Kit provides a complete solution for Chromatin Immunoprecipitation, including columns and reagents for DNA purification as well as an integrated protocol for ChIP DNA amplification with the GenomePlex(R) Whole Genome Amplification Kit. This flexible format allows for immunoprecipitation and purification of DNA from mammalian cells or tissue in a convenient microwell format.

ChIP is an innovative technology that enables scientists to investigate complex DNA-protein interactions in vivo, potentially increasing the speed and accuracy of disease research and drug discovery. The Imprint(TM) ChIP Kit provides researchers with rapid and accurate results, enabling high-throughput, same-day downstream analyses via quantitative PCR, MS-PCR, and DNA sequencing as well as DNA microarray. With the shortest protocol time and highest throughput capabilities on the market, the Imprint(TM) ChIP Kit, offers significant time and cost savings to epigenetic researchers.

Epiontis..Our novel analytical products, based on DNA methylation, are aimed at making Regenerative Medicine safer and better. Methylation analysis is the most appropriate technology for Quality Control (QC) of cells. Such QC is essential for cell therapy appproaches, which are seen as a very promising area of the health care market. Epiontis offers its QC-tool to partners in this industry, i.e., to companies that produce cell therapeutics. Thus, Epiontis safeguards the patients by ensuring that cell therapies are help- rather than harmful.

Epiontis is supported by a network of renowned academic partners and companies with expertise in Regenerative Medicine and DNA methylation. The company is based in Berlin, Germany

Constellation isn't the only company trying to mine epigenetics. Venture capital firms MPM Capital of Boston and Kleiner Perkins Caufield & Byers have quietly launched EpiZyme Inc., an epigenetics company focused on drugs for cancer and other diseases. The five-month-old biotech, which has office space in Waltham and North Carolina.

The Epigenetic link: http://epigenie.com/

Symbol Last Trade High Low Open Prev Close Change
ROSG 4.10 N/A N/A N/A 4.10 0.00%
Rosetta Genomics

Rosetta Genomics Licenses microRNA Genes from Rockefeller University
Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
Regulus Therapeutics, GlaxoSmithKline, Rosetta Genomics, University of California, Irvine, Isis Pharmaceuticals, Marligen Biosciences, Genisphere
UC Irvine to Validate MicroRNA Dx Tests for Rosetta Genomics
Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology

IVGN 93.92 N/A N/A N/A 93.92 0.00%
Invitrogen Corp

Invitrogen doubles its profits during Q1
PerkinElmer, Thermo Fisher Scientific, Invitrogen, Michigan High-Throughput Screening Center, US Department of Health and Human Services, Digilab Genomic Solutions, CyBio, Caliper Life Sciences, CytRx
Invitrogen Launches New Product For 3D Cell Culture
Invitrogen to Present at Upcoming Investor Conferences
Invitrogen "outperform," target price raised

QGEN 21.99 N/A N/A N/A 21.99 0.00%
Qiagen Nv

QIAGEN and BioHelix Enter Into
QIAGEN And BioHelix Enter Into Licensing Agreement
QIAGEN and BioHelix Enter Into Licensing Agreement
Webcast Alert: QIAGEN NV Announces First Quarter 2008 Earnings Conference Call
Webcast of QIAGEN NV's (Nasdaq: QGEN) First Quarter 2008 Financial Results Call Set for May 6

ABI 31.25 N/A N/A N/A 31.25 0.00%
Applera Corp-appl

Investment Firm Ups Stake in ABI; Encourages Board to Seek 'Strategic Alternatives'
Baylor College Of Medicine To Use Applied Biosystems Genetic
Applied Biosystems "outperform," target price reduced - newratings.com
ABI MS Growth Continues to Slow, Total Revs up 4.3 Percent for Q3
Applied Biosystems, Celera shares fall on earnings reports

AFFX 0.00 N/A N/A N/A N/A N/A
Affx

Affymetrix to Webcast Presentations at May Financial Conferences
Affymetrix Learns About Inertia
Affymetrix reports increase in Q1 revenue
Affymetrix "outperform," target price reduced - newratings.com
Affymetrix in pact with Avesthagen

ILMN 78.00 N/A N/A N/A 78.00 0.00%
Illumina Inc

Illumina and Genpathway Announce Partnership to Provide Whole-Genome ChIP-Sequencing Services
Illumina president and CEO sells 10,000 shares
Illumina to Present at Upcoming Investment Conferences in May
Fasteris Buys Second Illumina Genome Analyzer
Illumina Ignites

SQNM 6.10 N/A N/A N/A 6.10 0.00%
Sequenom Inc

Sequenom initiated with "neutral"
Sequenom to Hold 2008 First Quarter Financial Results Conference Call on April 30
Sequenom to Hold 2008 First Quarter Financial Results Conference Call on April 30
Pre-market: Sequenom, Akeena Solar and TASER International lead small-cap volume
Movers Roundup: Helix, Sequenom

CPHD 19.61 N/A N/A N/A 19.61 0.00%
Cepheid Inc

UBS Upgrades Cepheid Stock, But Lowers Price Target
Cepheid (CPHD) NewsBite - Cepheid Higher on Upgrade
Cepheid Slides Below 200-Day Moving Average [CPHD]
Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
Hang With Hurco And Cepheid

A 30.56 N/A N/A N/A 30.56 0.00%
Agilent Tech Inc

Agilent upgrades RFIC simulation software
Industries First Triple Play Test Solution From Agilent
Agilent Technologies integrates Quantum Data Support into HDMI automation solution
Oscilloscope training is made to measure
TRADE NEWS: Agilent Technologies Announces 10x Faster Planar 3-D Electromagnetic Simulation

LMNX 19.35 N/A N/A N/A 19.35 0.00%
Luminex Corp

Luminex Corporation First Quarter Earnings Release Scheduled for May 8, 2008
Luminex "buy," target price raised
Wageningen UR Teams with Luminex to Develop Multiplex Screening Solutions for Agro Biotechnology Market
Luminex Announces Executive Management Changes
Luminex inks sales, distribution deal with Abbott for xTAG panel

MIL 69.77 N/A N/A N/A 69.77 0.00%
Millipore Cp

Free reference for sample prep and
Open Biosytems, Invitrogen, Caliper Life Sciences, Promega, BioFocus DPI, Genedata, IonGate, Millipore, CELLnTEC Advanced Cell Systems
Millipore Announces Date and Time of First Quarter Earnings Release and Webcast
Millipore Launches Progenitor Cell-Enriched Primary Human Epithelial Cell Cultures
Millipore (MIL) NewsBite

SIAL 58.03 N/A N/A N/A 58.03 0.00%
Sigma Aldrich Cp

Sigma-Aldrich unit SAFC Hitech expanding in Wisconsin
Sigma-Aldrich Corporation Annual Shareholders Meeting
Sigma-Aldrich Sales Rise 14.9 Percent; Raises 2008 EPS Forecast
Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%.
Market Report -- In Play (SIAL)

ALNY 25.68 N/A N/A N/A 25.68 0.00%
Alnylam Pharmaceu

Market Report -- In Play (ALNY)
Alnylam and Collaborators at MIT Publish Research on the Discovery of 'Lipidoids', a Novel Class of Lipid-Based Molecules for the Delivery of RNAi Therapeutics
Morgan Stanley Global Healthcare Unplugged Conference
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News
Big Deal for Small RNAs

ISIS 12.11 N/A N/A N/A 12.11 0.00%
Isis Pharm Inc

FDA Moves Isis' Finish Line
Isis and Genzyme Must Prove
Genzyme Q1 Profit Falls On Isis Investment; Sees Q2 Non-GAAP EPS In Mid $0.90s - Update 2 [GENZ]
Genzyme reports lower profit on Isis deal charges
InvestSource Inc.: Caterpillar Earnings Up 13 Percent

Surely, there are some "gems" in them thar hills......

Peace,

**PL1**